Renin-angiotensin system/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett |
imported>Robert Badgett |
||
Line 23: | Line 23: | ||
{{r|Angiotensin-converting enzyme inhibitor}} | {{r|Angiotensin-converting enzyme inhibitor}} | ||
{{r|Hypertension}} | {{r|Hypertension}} | ||
{{r| | {{r|Kallikrein-kinin system}} |
Revision as of 23:37, 15 June 2008
- See also changes related to Renin-angiotensin system, or pages that link to Renin-angiotensin system or to this page or whose text contains "Renin-angiotensin system".
Parent topics
- Blood pressure [r]: Pressure of the blood on the arteries and other blood vessels. [e]
Subtopics
- Renin [r]: A highly specific (Leu-Leu) endopeptidase that generates angiotensin I from its precursor angiotensinogen, leading to a cascade of reactions which elevate blood pressure and increase sodium retention by the kidney in the renin-angiotensin system. [e]
- Angiotensin [r]: Oligopeptides which are important in the regulation of blood pressure (vasoconstriction) and fluid homeostasis via the renin-angiotensin system. These include angiotensins derived naturally from precursor angiotensinogen, and those synthesized. [e]
- Angiotensin receptor [r]: Cell surface proteins that bind angiotensins and trigger intracellular changes influencing the behavior of cells. [e]
- Angiotensin II receptor antagonist [r]: Agents that antagonize angiotensin II type 1 receptor. Included are angiotensin II analogs such as saralasin and biphenylimidazoles such as losartan. Some are used as antihypertensive agents. [e]
- Angiotensin-converting enzyme inhibitor [r]: Drugs mainly used to treat hypertension and heart failure, by hemodynamic effect inhibiting the renin-angiotensin system. [e]
- Hypertension [r]: A multisystem disease whose hallmark is the elevation of blood pressure. [e]
- Kallikrein-kinin system [r]: System of metabolic interactions by products produced in the distal nephron of the kidney. [e]